Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD
NCT07491523
·
clinicaltrials.gov ↗
RECRUITING
Status
35
Enrollment
OTHER
Sponsor class
Conditions
SSc-Systemic Sclerosis
Interventions
DRUG:
Antifibrotic drugs (nidanib or pirfenidone)
DRUG:
MMF Immunosuppression
Sponsor
University of Patras